Pamela J. Cramer - 26 Jul 2021 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Human Resources Officer
Signature
/s/ Hunter Smith, attorney-in-fact for Pamela J. Cramer
Issuer symbol
RYTM
Transactions as of
26 Jul 2021
Net transactions value
$0
Form type
4
Filing time
27 Jul 2021, 20:12:15 UTC
Next filing
11 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 26 Jul 2021 Common Stock 75,000 $19.02 Direct F1
transaction RYTM Restricted Stock Units Award $0 +12,500 $0.000000 12,500 26 Jul 2021 Common Stock 12,500 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on July 26, 2021. 25% of the shares subject to the option will vest and become exercisable on July 26, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F3 The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.